Request for Covid-19 Impact Assessment of this Report
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
Market Trends
Technology Development
Market Development
Major Industry Development
Regional Development
Enterprise Development
Labor Market Development
IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND
Overview
Sales Volume of Pharmaceuticals by Region
Mental Illness Drugs Sales Volume
Haloperido
Chlorpromazine
Ziprasidone
Olanzapine
Clozapine
Quetiapine
Aripiprazole
Risperidone
Fluoxetine
Other Mental Illness Drugs
Mental Illness Imports and Exports
Mental Illness Drugs Imports
Mental Illness Exports
Pricing Trend
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND
Mental Illness Drugs Sales Volume
Demand of Mental Illness Drugs by Region
Haloperido Sales Volume
Chlorpromazine Sales Volume
Ziprasidone Sales Volume
Olanzapine Sales Volume
Clozapine Sales Volume
Quetiapine Sales Volume
Aripiprazole Sales Volume
Risperidone Sales Volume
Fluoxetine Sales Volume
Other Mental Illness Drugs Sales Volume
China Mental Illness Drugs Imports and Exports
LIST OF CHARTS
I. INTRODUCTION
China’s Mental Illness Drugs Output, Capacity, Demand
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND
Mental Illness Drugs Sales Volume in China
Haloperido Sales Volume
Chlorpromazine Sales Volume
Ziprasidone Sales Volume
Olanzapine Sales Volume
Clozapine Sales Volume
Quetiapine Sales Volume
Aripiprazole Sales Volume
Risperidone Sales Volume
Fluoxetine Sales Volume
Total Mental Illness Drugs Imports and Exports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...